Ainos, INC. (AIMDW) — 10-Q Filings

10-Q Filings (5)

• Ainos' Losses Mount Amid Revenue Growth, Cash Drains — Nov 13, 2025 Risk: high
  Ainos, Inc. (AIMDW) reported a net loss of $10,302,714 for the nine months ended September 30, 2025, a slight increase from the $10,209,149 net loss in the prio
• Ainos' Losses Widen to $7.37M Amid Cash Burn, Reverse Stock Split — Aug 13, 2025 Risk: high
  Ainos, Inc. (AIMDW) reported a net loss of $7,371,012 for the six months ended June 30, 2025, an increase from a net loss of $6,509,832 for the same period in 2
• Ainos, Inc. Files 10-Q for Q1 2025 — May 14, 2025 Risk: low
  Ainos, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Amarillo Biosciences Inc., is in the pharmaceutical preparations industry
• Ainos, Inc. Files Q3 2024 10-Q Report — Nov 6, 2024 Risk: medium
  Ainos, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Amarillo Biosciences Inc., is in the pharmaceutical preparat
• Ainos, Inc. Files 10-Q for Period Ending March 31, 2024 — May 13, 2024 Risk: low
  Ainos, Inc. (AIMDW) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Ainos, Inc. filed a 10-Q report for the period ending March 31, 2024. The comp

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX